To address these issues, in this study, we utilized a single‐component dual‐functional prodrug strategy to develop a system in which the photosensitizer MB and a COX‐2 inhibitor were activated by tumor‐specific microenvironment‐generated hypochlorous acid (HOCl). The gene discussed is PTGS2; the disease is neoplasm.